europeanpharmaceuticalreviewJanuary 19, 2020
Tag: EFPIA , Medicine , Europe
Medicine shortages may negatively impact care and patient experience, the European Federation of Pharmaceutical Industries and Associations (EFPIA) has said.
It said that shortages should be a priority of industry, supply chain stakeholders and national competent authorities and deserve more than empathy or ‘lip-service’ but serious engagement and action. It also states that it welcomes initiatives to address genuine shortages of medicinal products.
Pharmaceutical companies should address issues relating to the manufacturing and supply of medicines and vaccines within their control to ensure the continuity of supply to people who need them, the EFPIA said. "This is, however, a complex issue involving multiple stakeholders and we need the active engagement and support of all of them to address this and minimise any negative impact on patient access."
EFPIA has said it calls for:
"Measures considered to address this issue should be proportionate and provide efficient, workable solutions that serve public health needs," the EFPIA continued. "It is key to provide the right conditions and business environment to support the long-term sustainability of supply. This includes predictable and fair pricing and market access systems that reflect the various economic and healthcare needs across Europe."
Register as Visitor to CPhI China 2020!
-----------------------------------------------------------------------
Editor's Note:
En-CPhI.CN is a vertical B2B online trade platform serving the pharmaceutical industry,
for any copyright disputes involved in the articles,
please email: Julia.Zhang@imsinoexpo.com to motify or remove the content.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: